Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Bone and Mineral Metabolism"
DOI: 10.1007/s00774-021-01250-1
Abstract: Measurement of fibroblast growth factor 23 (FGF23) has been reported to be clinically useful for the differential diagnosis of chronic hypophosphatemia. However, assays for research use only are available in Japan. Thus, the objective of… read more here.
Keywords: fgf23; chemiluminescent enzyme; fgf23 related; hypophosphatemic rickets ... See more keywords